Author

Alessia Ogareva

Observed names: A. A. Ogareva, A. Ogareva, A.A. Ogareva

Institution: Ipsen (France)

Observed institutions: Russian University of Medicine, Ipsen (France)

ORCID: 0000-0003-0538-8107

Observed ORCID: 0000-0003-0538-8107

OpenAlex ID: A5076626611

Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review

2024 · Janet Brown, Daniele Santini, et al. · Cancer Treatment Reviews · 17

Features of dental care provision for the child population in subjects of the Russian Federation in 2020 and 2021

2023 · O. O. Yanushevich, L. P. Kiselnikova, et al. · Pediatric dentistry and dental prophylaxis · 7

Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review

2025 · Natalie Charnley, Kate Fife, et al. · Cancer Treatment Reviews · 6

Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER study

2025 · D. Cella, M. Derosa, et al. · ESMO Open · 4

Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent Therapy

2025 · Marc-Oliver Grimm, Emma Karim, et al. · Oncology and Therapy · 2

Assessment of changes in the parameters of the quality of life of children aged 14—15 years with chronic catarrhal gingivitis after a complex of therapeutic and preventive measures

2022 · L.P. Kiselnikova, T.E. Zueva, et al. · Stomatology · 2

Erratum to “Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review”. [Cancer Treat. Rev. 140 (2025) 103024]

2026 · Natalie Charnley, Kate Fife, et al. · Cancer Treatment Reviews · 1

Health-related quality of life (HRQoL) profile and clinical outcomes in first-line (1L) advanced renal cell carcinoma (aRCC): A modelling analysis based on CheckMate 9ER (CM9ER) trial.

2024 · Jens Bedke, Rachel H. Giles, et al. · Journal of Clinical Oncology · 1

Summary of Research: Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent Therapy

2026 · Marc‑Oliver Grimm, Emma Karim, et al. · Advances in Therapy

Mapping patient experiences: Addressing gaps in care for people living with localised renal cell carcinoma

2025 · D. Maskens, D. Brézillon, et al. · European Urology Open Science

Works count: 10

Citation count: 40

H-index: 4

I10-index: 1